AstraZeneca PLC (OTCMKTS:AZNCF – Get Free Report)’s share price traded down 1.6% on Friday . The stock traded as low as $155.14 and last traded at $155.14. 849 shares were traded during mid-day trading, a decline of 70% from the average session volume of 2,860 shares. The stock had previously closed at $157.73.
AstraZeneca Stock Down 1.6 %
The stock has a 50 day simple moving average of $162.79 and a 200-day simple moving average of $152.23.
AstraZeneca Cuts Dividend
The firm also recently announced a dividend, which was paid on Monday, September 9th. Investors of record on Friday, August 9th were given a dividend of $1.00 per share. The ex-dividend date of this dividend was Wednesday, August 7th. AstraZeneca’s dividend payout ratio is currently 343.14%.
Institutional Inflows and Outflows
About AstraZeneca
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.
Recommended Stories
- Five stocks we like better than AstraZeneca
- Best Stocks Under $5.00
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- What does consumer price index measure?
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- High Flyers: 3 Natural Gas Stocks for March 2022
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for AstraZeneca Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca and related companies with MarketBeat.com's FREE daily email newsletter.